Are you a new member? Sign up now
Login area
| Sign up
close
ATACAND - 16mg - 28
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C09CA06 | B | Candesartan cilexetil - 16mg | 11995 | 164123/1 | ATACAND | 16mg | 28 | Tablet | Oral | Omnipharma | Klocke Pharma Service GmbH | Germany | 705,517 L.L | 23.08 | A1 | Cheplapharm Arzneimittel GmbH | Germany | 10/3/202 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C09CA06 | B | Candesartan cilexetil - 16mg | 1382 | 974041/02 | BLOPRESS | 16mg | 28 | Tablet | Oral | Abela Fr | The Arab Pharmaceutical Manufacturing PSC (APM) under license from Takeda Pharmaceutical company Ltd Japan | Jordan | 1,131,515 L.L | 23.08 | A2 | 10/3/202 | |||
| C09CA06 | G | Candesartan cilexetil - 16mg | 6822 | 218835/09 | ANDESART 16 | 16mg | 30 | Tablet | Oral | C. Catafago & Co | The Jordanian Pharmaceutical Manufacturing Co. (JPM) | Jordan | 665,202 L.L | 23.08 | A1 | The Jordanian Pharmaceutical Manufacturing & Co Ltd | Jordan | 10/3/202 | |
| C09CA06 | G | Candesartan cilexetil - 16mg | 11275 | 129422/1 | ARKANDA 16 | 16mg | 30 | Tablet | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 700,078 L.L | 23.08 | A1 | 10/3/202 | |||
| C09CA06 | G | Candesartan cilexetil - 16mg | 10110 | 83118/1 | CANDESARTAN BIOGARAN | 16mg | 30 | Tablet, scored | Oral | Commercial and Trading Ressources SAL (CTR) | Bluepharma Industria Farmaceutica SA | Portugal | 434,061 L.L | 23.08 | A1 | Laboratoires Biogaran | France | 10/3/202 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2025